Cargando…
N(6) ‐methyladenosine‐modified FAM111A‐DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A
As an epitranscriptomic modulation manner, N(6)‐methyladenosine (m(6)A) modification plays important roles in various diseases, including hepatocellular carcinoma (HCC). m(6)A modification affects the fate of RNAs. The potential contributions of m(6)A to the functions of RNA still need further inves...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475779/ https://www.ncbi.nlm.nih.gov/pubmed/37400994 http://dx.doi.org/10.1111/cas.15886 |